Sofinnova Partners Collaborates With NVIDIA to Accelerate European Life Sciences Startups
Amidst increasing demand for computational resources driven by AI, Sofinnova's portfolio companies will be able to access NVIDIA Blackwell and other NVIDIA architecture GPUs via NVIDIA DGX Cloud Lepton, an AI platform and marketplace connecting developers to global AI infrastructure.
BioCorteX, Bioptimus, Cure51 and Latent Labs —four of Europe's most promising digital medicine startups—will gain access to computing resources through DGX Cloud Lepton, enabling them to process biological data sets and run computational models that would have taken months, completing them in days.
Cure51, a pioneer in decoding the biology of exceptional cancer survivors, tested NVIDIA Parabricks, a GPU-accelerated genomics toolkit, and achieved up to 17x faster processing with NVIDIA H100 GPUs and more than 2x cost savings with NVIDIA L4 GPUs compared to their CPU baseline—dramatically accelerating their ability to analyze complex genomic data and scale their survivor-based insights.
"This collaboration supercharges computation for life sciences innovation," said Antoine Papiernik, Chairman and Managing Partner at Sofinnova Partners. "The convergence of biology, AI, computation, and data isn't just our investment thesis—it's the defining battleground of the next decade. From our Digital Medicine strategy to our own proprietary AI platform Sofinnova.ai, we recognize the transformative potential of AI across our entire domain. By securing access to NVIDIA's infrastructure, we're not just funding companies; we're empowering them with the computational backbone needed to outperform incumbents and redefine what's possible in drug discovery, precision medicine, and scalable solutions that address both human health and sustainability."
Learn more about NVIDIA DGX Cloud Lepton and view the official NVIDIA announcement.
###
About Sofinnova Partners
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise. Sofinnova Partners is a hands-on company builder across the entire value chain of life sciences investments, from seed to later-stage.
Founded in 1972, Sofinnova Partners is a deeply established venture capital firm in Europe, with 50 years of experience backing over 500 companies and creating market leaders around the globe. Today, Sofinnova Partners manages over €4 billion in assets. For more information, please visit: sofinnovapartners.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
37 minutes ago
- Yahoo
Stocks kick off July with surprising twist
Stocks kick off July with surprising twist originally appeared on TheStreet. It's been all about technology lately. After stocks found their footing in early April when President Donald Trump paused most reciprocal tariffs, clearing the way for trade deals, technology stocks have surged. The SPDR Technology ETF () gained 23% from April 9 through the end of the second quarter, handily out-pacing other sectors and the S&P 500, which returned 10.5% over the same period. 💵💰💰💵 The tech stock stars during the rally have been familiar names. For instance, AI darlings Nvidia and Palantir have skyrocketed a jaw-dropping 46% and 62%, respectively, after gaining 171% and 340% in 2024. The move has been impressive, but stocks don't rise or fall in a straight line forever. The third quarter has kicked off with a surprising list of stocks taking the baton from technology—at least for now. The rise in these down-and-outers could be fleeting, but after lagging technology stocks for a while, the recent action may make them intriguing, especially given technology stock valuations are arguably stratospheric. The stock market rally followed a massive sell-off that was fast and steep enough to cause most investor sentiment measures to flash deeply 'oversold.' Plenty of risks were behind the drop, including sticky inflation, growing joblessness, and uncertainty over how newly enacted tariffs may impact household and business combination of a weakening economy and cash-strapped consumers led many to think stagflation or recession is in the cards. The risk of such an economic reckoning isn't off the table. But the stock market is forward-looking, and investors appear to think most of the risk was priced into stocks at the early April lows. The trade deals announced so far with the UK and China aren't overly comprehensive, but they provide a blueprint that suggests tariffs might stay at current levels, providing much-needed clarity. If so, inflation caused by tariffs may be – dare I say it… transitory. A slight increase in inflation because of tariffs could prove manageable as long as it doesn't derail the likelihood of a friendly Fed. After cutting the Fed Funds Rate by 1% last year to stimulate the job market, the Fed has remained on the sidelines this year, awaiting clarity on how import taxes will impact inflation. However, most, including the Fed itself, expect rate cuts at some point this year. The Fed's dot-plot in June suggested its monetary policy will send interest rates a half-point lower by the end of 2025. () reduce rates by 1% () , while Morgan Stanley projects seven rate cuts. The prospect of lower rates driving economic growth, corporate revenue, and profit has reignited investors' animal spirits. Investors have also begun to model in potentially higher forward earnings estimates in the wake of a significant drop in the US Dollar. This helps financial results for companies that get sizable revenue from overseas, such as technology stocks. As a result, the S&P 500's forward price-to-earnings ratio has increased to nearly 22, an arguably rich valuation given historical returns tend to be middling once the stock market's P/E ratio exceeds 20. A return of optimism has caused some signals to flash overbought, suggesting that the stock rally may pause. For example, the S&P 500's relative strength index eclipsed 70 last week, a level that can foretell weakness. While concerning, not all stocks have to fall to work off that overbought condition. More Experts: Legendary fund manager sends blunt 9-word message on stock market tumble Major analyst unveils surprising gold price forecast for 2026 Jim Cramer sends strong message on Nvidia stock at all-time highs Many stocks have lagged technology stocks since April, and they may hold up or gain ground if high-flyers backfill some of their recent gains. We may already be seeing early signs of that happening. 'Underneath the surface, there's massive rotation underway,' wrote Bespoke in a note to clients. 'Q2's biggest winners are getting pummeled, while Q2's losers are soaring.' Bespoke crunched data on the Russell 2000, breaking stocks into ten baskets based on performance in the second quarter. On July 1, the stocks that were in the worst-performing basket last quarter jumped 3.3%, according to Bespoke. The best performers? Well, those stocks dropped an average of 2.3%. The 5.6% relative outperformance of the worst to best performers is pretty intriguing, but one day doesn't equal a trend. It's possible that much of the gains by the worst performers are tied to the calendar flip, as money managers waited until July 1 to lock in profits on some of their best performers and rebalance weights toward the laggards. "Tuesday felt like a lot of big upsets in the market as the 'seeded' players (the index movers) got rocked and the down-and-outers emerged," wrote veteran technical analyst Helene Meisler on TheStreet Pro. "Can the rally last this time? I think it has more than a day in it." Meisler thinks the rotation to the laggards may continue, but don't get too excited. We similarly saw the down-and-out stocks jump about one month ago, and they still wound up underperforming by the end of the month. Overall, Meisler thinks rotation may only help these stocks for a few weeks. She recommends that investors keep an eye on how the equal-weighted S&P 500 () performs relative to the more closely watched market-cap weighted S&P 500 () , which everyone uses as their benchmark, for kick off July with surprising twist first appeared on TheStreet on Jul 2, 2025 This story was originally reported by TheStreet on Jul 2, 2025, where it first appeared. 擷取數據時發生錯誤 登入存取你的投資組合 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤
Yahoo
37 minutes ago
- Yahoo
The Week In AI: Scaling Wars and Alignment Landmines
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report NVIDIA Corporation (NVDA) : Free Stock Analysis Report Marvell Technology, Inc. (MRVL) : Free Stock Analysis Report Taiwan Semiconductor Manufacturing Company Ltd. (TSM) : Free Stock Analysis Report Tesla, Inc. (TSLA) : Free Stock Analysis Report Meta Platforms, Inc. (META) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Insider
an hour ago
- Business Insider
Is Robinhood Stock (HOOD) Still a Buy After Surging to Record Highs? Analysts Say Yes
Robinhood Markets Inc. (HOOD) has soared to fresh all-time highs, driven by the company's recent product launches. Year-to-date, HOOD stock has climbed nearly 150%, reflecting growing investor confidence in its evolving business model. However, following this sharp rally, some investors are questioning whether the stock is still a buy. According to several top Wall Street analysts, the answer is yes. Don't Miss TipRanks' Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. What's Behind the Recent Surge? At a high-profile event this Monday, Robinhood introduced a series of new digital products, including tokenized stocks and ETFs, crypto perpetual futures, and staking services targeted at both U.S. and European markets. The announcement sent shares soaring, with the stock closing up 13% on the day. CEO Vlad Tenev said the launch is an important step in making Wall Street more accessible to people around the world, especially as interest in U.S. tech and AI stocks continues to grow. Top Analysts Hike Price Targets on HOOD Stock Analysts responded quickly, with several reports praising Robinhood's fast global growth and launch of new products. For instance, Cantor Fitzgerald's four-star-rated analyst Brett Knoblauch raised his price target on HOOD stock from $89 to $100 while keeping a Buy rating. He stated that the key takeaway from the recent event is that Robinhood is diving deeper into crypto, with new product launches expected to boost future revenue and profits. He added that Robinhood remains a must-own stock in the sector. The price target increase reflects stronger confidence in the company's growth plans and the value of its expanding product lineup. Similarly, KeyBanc's top-rated analyst, Alex Markgraff, lifted his price target from $60 to $110, implying a growth rate of 19% from the current level. Markgraff highlighted the launch of tokenized U.S. stocks for users in the EU, along with expanded crypto trading both in terms of geography and product variety. The firm noted that Robinhood demonstrated strong momentum in product development and expanded its range and depth of offerings at its first-ever crypto user event. Meanwhile, Barclays significantly raised its price target on Robinhood from $10 to $57. The firm highlighted Robinhood's strong focus on user experience, rapid product development, and low-cost structure as key standouts at the event. Is HOOD a Good Stock to Buy? According to TipRanks' consensus, HOOD stock has a Moderate Buy rating, based on 14 Buys, five Holds, and one Sell assigned in the last three months. The Robinhood Markets share price target of $74.16 implies a 19.7% downside over current trading levels.
